Capabilities
From the earliest days of COVID-19, King & Spalding has been at the forefront of vaccine developments, helping our leading pharmaceutical clients develop and implement strategies to contain the legal and reputational risks throughout their journey. At this critical juncture of distribution, our COVID-19 Vaccine Rollout Task Force is drawing on our industry knowledge and client relationships to serve as a guiding light and partner to our clients.
As you will see in the resources herein, we are focused on untangling the matrix of hurdles that arise in this unchartered landscape of developing state guidance intersecting with a rapidly evolving federal landscape. We are also examining the legislation developing to advise clients on immunity provisions and helping our clients prepare for potential investigations and litigation to follow.
Mandatory Employee Vaccinations Globally: Can You Require Your Employees To Get The COVID-19 Vaccine Everywhere?
Read More
January 20, 2022
Supreme Court Stays OSHA Vaccine-or-Test Mandate for Large Businesses
December 30, 2021
Select Subcommittee on the Coronavirus Crisis Ends 2021 With Several Open Investigations and Promises for Continued Oversight Across Industries
December 10, 2021
OSHA Pushes Ahead With Final Vax Or Test Rule Despite Court Challenges
February 18, 2022
Amanda Sonneborn explains why the U.S. government may never mandate boosters for healthcare workers